Abstract A large number of molecular pathways have been implicated in the degeneration of axotomized motoneurons. We previously have demonstrated substantial differences in the survival rate of axotomized motoneurons across different rat strains. Identification of genetic differences underlying such naturally occurring strain differences is a powerful approach, also known as forward genetics, to gain knowledge of mechanisms relevant for complex diseases, like injury-induced neurodegeneration. Overlapping congenic rat strains were used to fine map a gene region on rat chromosome eight previously shown to regulate motoneuron survival after ventral root avulsion. The smallest genetic fragment, R5, contains 35 genes and displays a highly significant regulatory effect on motoneuron survival. Furthermore, expression profiling in a F2(DAxPVG) intercross demonstrates one single cis-regulated gene within the R5 fragment; Gsta4, encoding glutathione S-transferase alpha-4. Confirmation with real-time PCR shows higher Gsta4 expression in PVG compared with DA both in naïve animals and at several time points after injury. Immunolabeling with a custom made rat Gsta4 antibody demonstrates a neuronal staining pattern, with a strong cytoplasmic labeling of motoneurons. These results demonstrate and map naturally occurring genetic differences in the expression of Gsta4 is associated both with a highly significant increase in the survival of axotomized motoneurons and with a trans-regulation of several molecular pathways involved in neurodegenerative processes. This adds to a large body of evidence implicating lipid peroxidation as an important pathway for neurodegeneration.
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Background
Great progress has in the last decades been made in the understanding of cellular pathways involved in neurodegeneration using experimental models (Schmidt and Ferger 2001; Kato 2008; Aktas et al. 2007; Centonze et al. 2010; Pitkänen et al. 2005) . In particular, transgenic mouse models have been proven useful for studying the mechanistic involvement of selected candidate genes (Trancikova et al. 2011; Sasaki et al. 2006; Giralt et al. 2009 ). However, little is known about the nature of genetic influences in complex traits. Even if many neurological diseases feature elements of neurodegeneration, knowledge of predisposing genes is limited almost entirely to monogenic or familial traits, while very little is known about genetic risk factors in the more frequent sporadic cases (Tsuji 2010) . The most frequent forms of neurodegenerative diseases of the CNS are complex in nature, with both genetic and environmental influences. The complexity implies that there are many genes contributing to a small increase in disease risk, in turn interacting with environmental factors, together making it difficult to identify underlying genes and mechanisms. One approach to unravel genetically modified genes and pathways is by taking advantage of naturally occurring phenotypic differences across different inbred rodent strains, which also enables to control for variance due to environmental factors. This strategy is sometimes referred to as forward genetics, as opposed to reverse genetics used in transgenic models. Such phenotypic differences between strains can be linked to restricted gene regions by mapping of quantitative trait loci (QTLs) in an F2 intercross. Usually, these gene regions are still large and other strategies, such as fine mapping in advanced intercross lines (AIL) or with overlapping congenic strains, where a small fragment is transferred from one strain to the other, will be needed to provide information at the single gene level (Darvasi and Soller 1995) . More recently, the combination of trait linkage analysis with mapping of expression QTLs using powerful gene profiling techniques has proven useful for gene positioning (Hubner et al. 2005; Behmoaras et al. 2008) . The goal of the forward genetics approach is to find the gene(s) behind the observed trait, which will yield important insights into the molecular basis for the studied phenotype. By now there are several examples of evolutionary conservation of this type of genetic ''bottle necks'' across different species and with relevance for human diseases (Aitman et al. 1999; Behmoaras et al. 2008; Swanberg et al. 2005; Jagodic et al. 2009; Olofsson et al. 2003; Samuelson et al. 2007) .
In previous studies, we have documented substantial differences in the rate of survival of axotomized motoneurons across different rat strains using a simple and reproducible model of mechanical nerve injury; ventral root avulsion (VRA) (Lundberg et al. 2001) . In a F2(DAxPVG) intercross, we identified a gene region on chromosome 8, VRA1, with significant linkage to loss of motoneurons (Lidman et al. 2003) . VRA1 was recently fine mapped using AIL and congenic strains, reducing the size of the interval to 9 Mb comprising 45 protein coding genes (Swanberg et al. 2009) . In this study, we have performed global expression QTL (eQTL) mapping in a F2(DAxPVG) intercross analyzed with Affymetrix Rat Gene 1.0 ST Array chips 5 days after VRA identifying a single strong candidate, glutathione S-transferase alpha4 (Gsta4), to be responsible for a substantial part of the observed difference in motoneuron survival after VRA between the two strains.
Methods

Animals and Breeding
The DA (RT1 av1 ) strain was originally kindly provided by Professor Hans Hedrich (Medizinische Hochschule, Hannover, Germany), while the MHC congenic PVG-RT1 av1 (hereafter called PVG av1 ) strain was obtained from Harlan UK Ltd (Blackthorn, UK). All animals were bred in our inhouse breeding facility under specific pathogen-free and climate-controlled conditions with 12 h light/dark cycles, housed in polystyrene cages containing wood shavings and fed standard rodent chow and water ad libitum.
The (Swanberg et al. 2009 ) to the DA strain. Only males were studied in the experiments presented here, since these proved to have less variation within groups compared with females in previous studies (Swanberg et al. 2009 ). The R5 congenic excludes 10 genes present in the R3 congenic reducing the number to 35.
To generate the F2(DAxPVG av1 ) intercross, breeding couples composed of both DA and PVG av1 male and female rats, respectively, were setup to generate two groups of offspring (F1) (DAxPVG av1 ) and (PVG av1 xDA). These two groups were subsequently mated reciprocally to generate four groups of F2 progeny. Both female and male rats were included, and a total of 144 F2 animals were used for the microarray study and eQTL mapping.
Nerve Lesion
All animals were subjected to unilateral avulsion of the left L3-L5 ventral roots under standardized conditions and in deep isoflurane anesthesia at an age of 9-12 weeks with a post-operative survival time of 1-21 days (±2 h), after which animals were killed with CO 2 and perfused with cold 19 PBS containing Heparin (LEO Pharma AB, Malmö, Sweden) (10 IE/ml). After dissection, the spinal cords were carefully examined in a dissection microscope to verify the completeness of the lesion. In no case, did the microscopic examination reveal signs of hemorrhage, necrotic zones or direct damage to the cord. Animals with incomplete lesions were excluded from further analysis. In the cohorts with parental and congenic animals, the ipsilateral ventral cord-quadrant of L3 was dissected and snap frozen for subsequent mRNA extraction. The L4-L5 segments were frozen on dry ice for histological analysis. In the F2 cohort, the ipsilateral ventral quadrant of the L4 segment was dissected for expressional profiling. Tissues were stored at -80°C. All experiments in this study were approved by the local ethical committee for animal experimentation (Stockholms Norra Djurförsöksetiska Nämnd) and comply with the guidelines from the Swedish National Board for Laboratory Animals and the European Community Council Directive (86/609/EEC).
Motoneuron Counts
Serial transverse frozen sections (14 lm) of tissue from the L4 segment of the spinal cord were cut with a cryostat. Neuronal counts of cresyl violet counterstained sections were performed as described previously (Lundberg et al. 2001; Lidman et al. 2003) . In brief, counts of motoneurons with a visible nucleus were performed blindly by a single observer on every fifth section with a total of 20 sections from each rat, in total covering a distance of approximately 2 mm in the rostro-caudal axis. Each slide contained sections from nine rats mounted in a similar fashion in order to reduce the risk of bias. In a previous study, the reduction in mean soma size of axotomized cells as compared to unlesioned cells on the contralateral side was highly similar (-27 to 28%) regardless of sex or strain (Lidman et al. 2003) . No correction for cell shrinkage was performed here as this feature is expected to affect the studied cell populations to a similar degree. The degree of neurodegeneration is presented as a ratio of the total number of motoneurons on lesioned and unlesioned sides, respectively, in each rat.
Design-based stereology neuronal counts were used to corroborate the results regarding differences in motoneuron survival between parental strains and the R5 congenic.
These animals were transcardially perfused with 50 ml PBS followed by 250 ml phosphate-buffered paraformaldehyde. The L4 spinal cord segment was dissected and embedded in paraffin in blocks of 5-6 spinal cords. The cord segments were cut vertically to their longitudinal axis with a microtome (Microm, HM 355) to produce 30-lm thick sections. A random systematic sampling combined with the optical fractionator was used to count the surviving motoneurons both ipsilateral and contralateral to the injury (West and Gundersen 1990) . Every eighth section was systematically sampled and stained with toluidine blue (sampling fraction ssf = 1/8), where the first section was chosen at random.
The stained sections were analyzed on a modified Zeiss axioplan microscope with a motorized stage (Prior ProScan II, Cambridge, UK) and an electronic microcator for measurement of the position along the z-axis. Live images were obtained and viewed on two large monitors through a fast digital camera (PixeLINK, Ottawa, Canada). Motoneuron counting was performed using the newCAST software (Visiopharm, Hoersholm, Denmark). The border of the region to be quantified was outlined at 109 magnification and cell counting was performed using a Zeiss 409 oil objective (FLUAR, NA 1.30). A sampling frame with an area of 8,100 lm and a step length of 90 lm 9 90 lm was used resulting in an area sampling fraction (asf) equal to 1. For two animals, a z-axis distribution of the cell nucleoli was made and in that way a histogram was obtained in order to find the range for the dissector height in which the cell nucleoli densities were similar (unpublished data) . This range could be defined to be from 6 to 16 lm under the top of the section (height of the dissector = 10 lm). The thickness of the ipsilateral or contralateral area of section was also measured and weighed with the counted number of neurons, t Q À ðhsf ¼ t Q À =10 lmÞ in field of views (Dorph-Petersen et al. 2001) . Motoneurons that fulfilled the sampling criteria were counted (RQ -) and their total numbers (N total ) were estimated for the whole L4 segment, ipsilaterally or contralaterally, using the equation:
The degree of motoneuron degeneration was calculated in each rat as a ratio of the total number of motoneurons ipsilaterally/contralaterally to the injury (N total-ipsi / N total-contra ). In this study, the number of motoneurons localized in the lateral ventral horn of the L4 segment of the spinal cord was estimated. Motoneurons were identified by their morphology and size. The counting unit was the nucleolus. The error variance of the counting procedure was estimated according to Gundersen et al. (1999) and was on average CE ipsi = 0.14 for the ipsilateral side and CE contra = 0.09 for the contralateral side.
Genotyping
The F2 intercross was genotyped with 113 microsatellite markers evenly distributed across the genome, with an average distance of 20 cM based on previous knowledge of optimum spacing (Darvasi and Soller 1994) . The successful genotyping rate was 95.3%. The size of the congenic fragment was also determined with microsatellite markers.
Briefly, genomic DNA was extracted from tail tips or ear clippings using a standard protocol. PCR-primers for polymorphic simple sequence length polymorphisms (SSLPs) were selected from available internet databases [Rat Genome Database (http://www.rgd.mcw.edu) and Ensembl (http://www.ensembl.org)]. The primers were purchased from MWG (Ebersberg, Germany) and Applied Biosystems (Carlsbad, CA). PCR amplification was performed using a standard protocol, and PCR products were separated using an electrophoresis capillary sequencer (ABI3730) and analyzed with GeneMapper v3.7 software (Applied Biosystems). Genomic DNA from DA and PVG av1 rats were included for each marker.
Global Gene Expression Profiling
The microarray analysis was performed at the microarray core facility of Karolinska Institutet using Affymetrix Rat gene 1.0 ST Array chips (Affymetrix, Santa Clara, CA). One hundred ng of total RNA was used for the synthesis of double-stranded cDNA. RNA was reverse transcribed using a whole transcript cDNA synthesis and amplification kit (Affymetrix UK Ltd, High Wycombe, UK). The resulting biotin-labeled cRNA was purified using an IVT clean-up kit (Affymetrix) and quantified using a NanoDrop ND-1000 Spectrophotometer (A260/280; NanoDrop Technologies, Wilmington, DE). An aliquot (5.5 lg) of cRNA was fragmented by heat and ion-mediated hydrolysis at 94°C for 35 min. Confirmation of RNA quality was assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Target labeling, as well as array hybridization, washing and staining were performed as described in the GeneChip Whole Transcript (WT) Sense Target Labeling manual (http://www.affymetrix.com ). Arrays were scanned using the GeneChip Scanner 3000 7G and the GeneChip Command Console (Affymetrix) with default setup. Two lg of total RNA was used for each sample. Probe details can be found at the Affymetrix website (http://www.affymetrix.com).
Microarray gene expression data were normalized using the RMA algorithm (Irizarry et al. 2003) implemented in the Bioconductor package ''oligo''. Briefly, raw expression intensities were background corrected, quantile normalized, log2 transformed and summarized on probe set level. On the Rat gene ST 1.0 array genes are represented by multiple probe sets. Affymetrix assigns these probe sets to transcript clusters. We have used average expression values of all probe sets annotated to a transcript cluster to measure expression on the level of a gene based on annotation from Bioconductor package ''pd.ragene.1.0.st.v1''. The microarray data are available in MIAME-compliant (minimal information about a microarray experiments) format at the ArrayExpress Database (http://www.ebi.ac.uk/arrayexpress ) under accession code E-MTAB-303.
eQTL Mapping and Statistics
Expression QTLs were mapped for all 27342 transcript clusters using the QTL reaper software (Wang et al. 2003) against the 113 genomic markers in the F2 cohort with marker regression. In order to assess genome-wide significance of eQTLs, we performed 10 6 permutations, where P \ 0.01 at a genome-wide level was considered significant. We classified eQTLs into cis-or trans-acting according to the distance between the locations of genetic marker and the affected transcript. If the distance was smaller than 20 Mb, we assumed cis-and otherwise transregulation. Effect plots for regulated targets at the markers in the region has been created with R using the package qtl . Statistical analysis of qPCR data and neuronal survival was performed with GraphPad Prism (GraphPad Software Inc., San Diego, CA).
Real-Time PCR
Total RNA was isolated from homogenized L3/L4 tissue using RNeasy mini kit (Qiagen, West Sussex, UK). RNA samples underwent 15 min on-column DNase digestion (Qiagen, 27 Kunitz units). cDNA was prepared by using reverse transcription with 10 ll total RNA using iScript (Bio-Rad, Hercules, CA). Amplification was performed using the iQ5 Real-Time PCR detection system for single time points and CFX384 system for the kinetic study (Bio-Rad). Primers were designed using the ABI Beacon software (Applied Biosystems). Primer specificity was assessed by using amplicon dissociation curves in each sample and with gel electrophoresis combined with silver staining. Relative quantitation of mRNA expression was performed using the Normalized Expression function in the iQ5 and CFX384 software. Samples without template served as controls. All samples were analyzed in triplicates.
Targets analyzed with RT-PCR were as follows: Gsta1 (Fw: CTGTGCGGTGGCTATTGG, Rev: TTCAT AATGGCTCTGGTCTGC), Gsta4 (Fw: CAGGAGTCAT GGAAGTCAAAC, Rev: TTCTCATATTGTTCTCTCG TCTC) and the housekeeping gene HPRT (Fw: CTCA TGGACTGATTATGGACAGGAC, Rev: GCAGGTCAG CAAAGAACTTATAGCC).
Production of Anti-Gsta4 Antibody
A custom made GSTA4 antibody was developed in rabbit by Capra Science (Ä ngelhom, Sweden). Since there is no crystal structure determined for rat Gsta4, tertiary structure prediction of the 222 aa sequence of rat Gsta4 was made from human crystal structure of Glutathione Transferase A2-2. The predicted model can be viewed at http://swiss model.expasy.org/?pid=smr01&uid=&token=&zid=async with use of the accession number: P14942.
For the antibody production, a C-terminal peptide (210-222: CGHYVDVVRTVLKF) with low alignment score for other GSTAs was synthesized and conjugated to KLH. Rabbit antiserum was collected after a series of injections with the conjugated peptide together with adjuvant. Specific antibody production toward the peptide was measured with Elisa. A Nunc-Immuno MaxiSorp plate was coated with the peptide and tested with both antiserum and pre-immune serum in dilution series 1:10-1 9 10 6 , with no signal in pre-immune serum and good signal in antisera. To generate peptide-specific antibodies, purified rabbit IgGfractions were affinity purified on a column coupled with the c-terminal Gsta4 peptide antibody was recovered with a final concentration of 1.0 mg/ml.
Western Blot and Immunohistochemistry
For Western blot, protein homogenate from spinal cord L3-L5 ipsilateral side 5 days after VRA was prepared by homogenizing *40 mg tissue in lysis buffer (150 mM NaCl, 50 mM Tris, 1% IGEPAL CA630, pH 8.0) with protease inhibitor [cOmplete (Roche)] with Qiagen Tissue Lyser LT for 4 min at 50 Hz. Samples were thereafter incubated at 4°C under gentle agitation for 20 min, centrifuged at 13,000 rpm for 10 min and the supernatant was recovered. Protein concentration was measured with Coomassie Plus TM protein assay reagent according to the manufacturer's instructions. 65 lg of protein from each sample was thereafter used and loaded on 12.5% polyacrylamide gel together with PageRuler TM Prestained Protein Ladder (Fermentas). The protein was transferred to a nitrocellulose membrane that was blocked in PBS-Tween containing 5% milk powder. Thereafter, the membrane was cut around 40 kDa according to the ladder and the lower part was incubated with Gsta4 antibody (1:1,000), while the upper part was incubated with Sigma Monoclonal bActin antibody Clone AC-15 (1:25 000) for 1 h. Secondary HRP-conjugated antibody [donkey anti-rabbit IgG HRPconjugated (1:2,000) (Amersham NA9340V)] was applied for 1 h on Gsta4 antibody followed by ECL solution (Amersham) for 1 min and exposure to Chemiluminescence film (Amersham Hyperfilm TM ECL). Films were developed and photographs were taken with Gel Doc TM XR?. The band intensities were calculated with Image Lab TM 3.0(BioRad). Further, peptide competition, where Gsta4 antibody had been incubated with peptide 1:5 for 3 h in room temperature, was run in parallel and used as negative control.
For immunolabeling, neurons were stained with NeuN (mouse, Chemicon). All antibodies were diluted to working concentration in solution containing 19 PBS, 1% BSA and 0.3% Trition. In brief, the sections were air-dried and rehydrated 3 9 10 min in 19 PBS and blocked with 19 PBS containing 1% BSA, 0.3% Triton and 3% donkey serum followed by incubation at 4°C over night with primary antibodies (Gsta4 1:100, NeuN 1:200). The slides were subsequently washed 3 9 10 min in PBS followed by 1 h incubation with the appropriate secondary antibodies, Alexa 488 conjugated donkey anti-mouse (1:200) and Alexa 594 conjugated donkey anti-rabbit (1:400) (Molecular Probes, Oregon, USA). Incubation with pre-immunization rabbit sera, antibody incubated 3 h with peptide and omission of primary antibodies was used as negative controls.
Micrographs were recorded on a Leica microscope system with Infinity X camera (DeltaPix, Denmark) and processed with the DpxView PRO software.
Results
Motoneuron Survival After VRA is Increased in the DAc8PVG-R5 Congenic Strain Motoneuron survival was initially determined 21 days after VRA in the following strains; the two parental strains, DA and PVG av1 (median survival 24 and 42%, respectively); DAc8PVG-R3 (31%); DAc8PVG-R5 (30%); and the reciprocal congenic strain PVGc8DA1 (36%) (Fig. 1a) . The motoneuron survival ratios were obtained by counting all large motoneurons in the lateral part of the ventral horn on the ipsilateral and contralateral sides, respectively, in 20 sections from each individual without correction for differences in cell size between lesioned and unlesioned cells. The results closely mirror our previous findings of an increased survival of axotomized motoneurons in the R3 congenic compared with DA and a decreased survival in the reciprocal PVGc8DA1 congenic compared with PVG (Swanberg et al. 2009 ). The smaller R5 congenic displayed a similar degree of motoneuron survival as the R3 congenic, supporting the existence of a regulatory influence mapping to within the 6.4 Mb interval of the R5 strain. Due to within group variability differences in motoneuron survival, they were not statistically significant after correction for multiple comparisons, except for DA and PVG av1 . In order to verify the motoneuron survival data from the initial analysis with a design-based (unbiased) methodology, stereology was used to estimate motoneuron number in a second independent experiment, which included the parental strains DA and PVG av1 (median survival 31 and 55%, respectively), and the R5 congenic (47%) (Fig. 1b) . Again, the difference in motoneuron survival between DA and the R5 congenic was of the same magnitude, but with increased statistical significance due to smaller within group variability, with P \ 0.001 for both comparison of DA versus PVG and DA versus R5. Both data sets show a close to 45 % increased survival in PVG compared to DA, with R5 displaying and intermediate phenotype. Stereology-based motoneuron counts are independent of differences in motoneuron size and shape between lesioned and unlesioned motoneurons, which probably explains the relatively higher survival ratios obtained with this method as compared to the initial model-based analysis. A representative spinal cord section from a DA rat is shown in Fig. 1c .
Expression QTL Mapping in F2(DAx PVG av1 ) at 5 days After VRA The eQTL mapping was performed at 5 days after VRA, a time point just prior to when most axotomized motoneurons degenerate (Piehl et al. 1999) , in 144 individuals from the F2(DAxPVG av1 ) cohort. Two markers in the VRA1 region were included in the global eQTL mapping, D8Rat26 (79.35 Mb) and D8Rat75 (89.56 Mb). In total, there were 41 transcripts, of which eight un-annotated, mapping to D8Rat26 with P \ 0.05 (Table 1) and 50, of which 11 un-annotated, to D8Rat75 (Table 2) , with 19 of the transcripts overlapping between the markers. With the preset genome-wide significance threshold level of P \ 0.01, the number of transcripts was reduced to 15 and 11, respectively. The strongest linkage to both genomic markers was for the glutathione S-transferase alpha4 subunit, Gsta4. This gene is cis-regulated with a genomic location at 83.17 Mb, i.e., just between the two markers. At both markers, this gene (transcript cluster id 10911797) maps with P = 0 and an lrs score of 47.34 and 47.43, respectively, which is several orders of magnitude stronger than any of the other transcripts. The effect plot of Gsta4 expression at the marker D8Rat26 shows higher expression of Gsta4 in animals homozygous for PVG alleles, with heterozygotes displaying an intermediate phenotype (Fig. 2a) .
There were two other cis-regulated transcripts with P \ 0.01 mapping to D8Rat26, however, none of them actually residing within the R5 fragment. In addition, there was one cis-regulated transcripts with P = 0.01 mapping to D8Rat75; ElovL4. This gene is located within the R3, but outside of the R5 fragment.
There are several transcripts implicated in neurodegenerative diseases that are trans-regulated by the two markers; for example, urocortin (Ucn), dual oxidase 1 (Duox1), copine 6 (Cpne6), and chemokine ligand 2 (Ccl2) are significantly linked to both markers. Ccl2 also maps to another position in the genome, D4Rat177 (P = 0.0055). Furthermore, D-amino acid oxidase (Dao) and cyp39a1 are among the strongest regulated transcripts at D8Rat26, where Dao also maps to a position on chromosome 1, D1Rat49 (P = 0.004).
To further explore strain differences in the expression of the other a-subclass glutathione S-transferase isoforms, all transcripts of this family (one to five) were checked for significant regulation in the F2 cohort (Table 3) . LOC501110, similar to glutathione S-transferase A1 (further on referred to as Gsta1) was found to be strongly cis-regulated from its position on chromosome 9 and Gsta3 showed a trans-regulation from chromosome 10. Effect plots of these transcripts are depicted in Fig. 2b , c. Interestingly, PVG proved to be a virtual null mutant of Gsta1, with extremely Expression of Gsta4 in Naïve Animals and at Different Time Points After VRA A kinetic study of the expression of Gsta4 in naïve DA and PVG rats, as well as at different time points after VRA revealed that PVG not only displays higher constitutive levels, but also significantly up regulates the expression after injury (Fig. 3a) . In contrast, expression of Gsta4 in the DA strain is not discernibly regulated at all after injury. Expression data at 5 days after VRA in the strains DA, PVG, DAc8PVG-R5, and PVGc8DA1 verify that strain differences in Gsta4 is cis-regulated (Fig. 3c) . PVG displays 40% higher expression compared with DA and in the DAc8PVG-R5 congenic levels are even higher than in PVG. Contrary to this, the reciprocal PVGc8DA1 expresses Gsta4 at the same level as DA. Also the expression of Gsta1 displays strong strain dependent differences, but with a reversed strain pattern, with virtually un-measurable levels in the PVG strain both in naïve animals ( Fig. 3d) and at 5 days after VRA (Fig. 3e) , which confirms the results from the F2 intercross. ) intercross population (n = 144). a Expression of Gsta4 at the marker D8Rat26 shows higher expression of Gsta4 in animals homozygous for PVG alleles (n = 36) compared to DA homozygots (n = 34), with heteroygotes (n = 69) displaying an intermediate phenotype. b Gsta1 is cis-regulated from its position on chromosome 9 (D9rat130), with extremely low levels observed in PVG homozygous individuals (n = 39/68/33 for DA/DA, DA/PVG and PVG/PVG, respectively). c Gsta3 shows trans-regulation from chromosome 10 (D10rat219). This transcript also displays lower levels in PVG homozygous animals (n = 29/66/ 36 for DA/DA, DA/PVG and PVG/ PVG, respectively). For all graphs and each genotype, the phenotypic mean is plotted, with error bars at ±1 SE as included in command plot.pxg in R/qtl Western Blot and Immunolabeling of Gsta4
Western blot of homogenates from L3-L5 segments with the custom made polyclonal antibody for Gsta4 revealed a single band just below the 26 kDa ladder band and thus showed that the peptide antibody also recognize the full length protein (Gsta4 = 25.51 kDa). When the membrane was incubated with the same antibody previously blocked Fig. 3 Expression of Gsta4 and Gsta1 in the spinal cord is strain dependent. a A kinetic study of the expression of Gsta4 in naïve animals as well as at different time points after VRA shows higher constitutive levels in PVG and a lack of injury-induced upregulation in DA. Number of rats in each group 0, 1, 3, 5, 7, and 14 dpi is 5/5, 5/5, 6/5, 6/5, 5/6, and 5/7 in DA/PVG, respectively. b Relative protein levels of Gsta4 as the quotient between band intensity of Gsta4 and b-actin in DA (n = 4) and PVG (N = 4) from whole cell homogenates of ipsilateral L3-L5 segment 5 days after VRA. Depicted are also two representative bands of each antibody and strain. c Expression differences map to the DAc8PVG-R5 fragment, since Gsta4 levels are significantly higher in the R5 congenic (n = 7) compared with DA (n = 6) and the reciprocal PVGc8DA1 (n = 6) have lost the PVG (n = 6) phenotype and displays the same levels as DA 5 days after VRA. Statistical analysis in a and b show results of ANOVA with Benferroni's multiple comparison test. Also Gsta1 displays strong strain dependent differences, but with a reversed strain pattern, with high levels in DA (n = 5) and virtually un-measurable levels in the PVG (n = 5) strain both in naïve animals (d) and at 5 days after VRA (n = 6/6 in DA/PVG) (e). Statistical analysis in d and e show results of Student's T test and all horizontal lines show median value for each group with the Gsta4 peptide, the expected band was missing. Also, quantification of protein levels from the ipsilateral side between DA and PVG, 5 days post-injury, showed the same pattern as mRNA levels (Fig. 3b) indicating that mRNA is translated into protein and that mRNA levels will affect enzymatic activity in the tissue.
Immunolabeling for Gsta4 reveals neuronal cytosolic staining co-localizing with NeuN in spinal cord sections, with positive labeling of both large motoneurons in the ventral horn and other neurons in all areas of the spinal cord gray matter. Further, no positive staining was detected in glial cells indicating that Gsta4 is primarily located in neurons. None of the negative controls, consisting of omission of primary antibody or serum/peptide competition had any neuronal staining. Both DA and PVG sections stain positive for Gsta4 and motoneurons from both strains are depicted in Fig. 4 . Motoneurons on both ipsi-and contralateral sides stained positive without discernible differences at 5 dpi.
Discussion
Using expression profiling in a F2(DAxPVG av1 ) intercross, we here demonstrate a single, strong cis-regulated eQTL in a small VRA1 congenic fragment regulating neuronal survival after nerve injury. The VRA1 region was originally discovered in a F2 intercross between the DA and PVG av1 strains (Lidman et al. 2003) . These strains were selected based on being extremes in terms of motoneuron survival in a panel of examined inbred rat strains (Lundberg et al. 2001) . Recently, the VRA1 effect was also reproduced using congenic strains (Swanberg et al. 2009 ). This represents the only unbiased gene mapping for a complex trait with axotomy-induced motoneuron death as outcome measure reported so far. The rationale for this type of strategy is to gain knowledge of the mechanisms that are relevant for complex disease conditions (Aitman et al. 2008 ). This approach differs from the identification of spontaneous causative genetic mutations such as, for example, in the Wnd mouse (Conforti et al. 2000) , which more resembles familial, monogenic trait diseases.
The eQTL identified here concerns the transcript Gsta4, encoding the glutathione S-transferase alpha 4 subunit. Glutathione S-transferase isoenzymes (GSTs) are designated by the subunit composition, e.g., GST A4-4 (Mannervik et al. 2005) . GSTs constitute a large family of proteins that, depending on structure and substrate selectivity, are sub-divided in the Alpha, Mu, Pi, Theta, Zeta, and Omega classes. Their function is mainly to catalyze the conjugation of reduced glutathione to a wide variety of substrates (Beckett and Hayes 1993) . This plays an important role in the detoxification and elimination of toxins and also of reactive endogenous compounds such as by-products of lipid peroxidation. 4-hydroxynonenal (4-HNE), malondialdehyde and acrolein are the main compounds generated from the peroxidation of polyunsaturated lipids and they all share an a, b unsaturated aldehyde moiety (Esterbauer et al. 1991) . They are also used as biomarkers for oxidative damage in tissue (Requena et al. 1996) . The alpha-class of GSTs may be of special relevance in the context of axotomy-induced motoneuron death, since they play a significant role in the detoxification of oxidative stress products and are abundant in tissues exposed to high levels of reactive oxygen species (ROS) (reviewed in Coles and Kadlubar 2005) . Elevated levels of ROS can be detected in various models of neurodegeneration after nerve trauma (Martin et al. 1999; Lieven et al. 2006; Geiger et al. 2002) .
Data on the cellular localization of Gsta4 in the CNS is still scarce. In an early publication, immunolabeling for Gsta4 (formerly annotated as Gst 8-8) was reported primarily in rat astrocytes and blood vessels (Johnson et al. 1993) . In a more recent publication, neuronal and vessel Gsta4 staining was found in normal human and Alzheimer disease brain sections (Desmots et al. 2001) . Due to the lack of commercially available antisera toward rat Gsta4, we here used a custom made antibody designed to have a high degree of specificity for the rat Gsta4 isoform.
Immunolabeling demonstrates a high degree of neuronal labeling as shown by the strict co-localization with NeuN in spinal cord sections. A neuronal localization is further supported by in situ hybridization data in mouse available at Allen Brain Atlas (http://mouse.brain-map.org/). Even if many substrates show considerable overlap between different GSTs, the GST A4-4 isoform is different because it displays conspicuously high enzymatic activity for compounds containing reactive carbonyl compounds such as 4-hydroxy-2-alkenals (a, b unsaturated aldehydes) (Hubatsch et al. 1998 ). This makes GST A4-4 particularly important for catalyzing the conjugation of 4-HNE to glutathione. Although there is sequence variation (66% similarity) between the human and rat Gsta4 (previously named rat GST 8-8) genes, both the human and rat enzyme display a similar substrate profile, with high efficacy for 4-hydroxy-2-alkenals and relatively lower affinity for other substrates (Hubatsch et al. 1998) . GST A4-4 displays the by far highest affinity for 4-HNE, but also other GSTs contribute to the total conjugation activity. This can be deduced from experiments performed in Gsta4 null mice, which retain 23-64% of the catalytic activity depending on the tissue (27% in brain), likely due to other GST isoforms with lower affinity (Engle et al. 2004) . For example, GSTA1-1, with a much more promiscuous substrate profile and activity toward a wide range of lipid peroxidation products, also show activity toward 4-HNE but 35-fold lower than GSTA4-4 (Zhao et al. 1999 ).
An increasing body of evidence connects 4-HNE with common chronic neurodegenerative diseases. Lipid peroxidation with generation of 4-HNE has been proposed to play a role in amyotrophic lateral sclerosis (ALS) (Pedersen et al. 1998 ), Alzheimer's (AD) (Lovell et al. 1997; Cutler et al. 2004 ) and Parkinson's (PD) diseases (Yoritaka et al. 1996; Selley 1998) . For example, Gsta4 knockout mice have shorter survival time after repeated low dose ip injection of paraquat compared with controls (Engle et al. 2004) . This is of particular importance in the context of CNS diseases since paraquat, a herbicide that induces oxidative stress and lipid peroxidation, has been extensively used in experimental models of Parkinson's disease and exposure to paraquat has also been implicated as a causal factor to human disease (Tanner et al. 2011) . It is also of interest that mutations in superoxide dismutase 1 (SOD1), the most frequent cause of familial ALS, concerns an enzyme that reduces superoxide radicals (Deng et al. 1993) . Various SOD1 transgenic mice have been extensively used for the study of ALS, since animals develop a spontaneous motoneuron disease in young adult life. In a recent global expression profiling study performed in 3-week-old SOD1 knockout mice, before onset of clinical symptoms, Gsta4 was found to be the only transcript to be markedly up-regulated, presumably as a compensatory mechanism to eliminate increased 4-HNE levels resulting from greater oxidative stress (Yoshihara et al. 2009 ). However, as in the case of SOD1 knockout mice, also Gsta4 null mice have recently been shown to activate compensatory mechanisms by increased Nfr2 activity and also show variable results depending on strain background (Singh et al. 2008 (Singh et al. , 2010 . However, although the studies on Gsta4 null mice provide us with important information about the role of Gsta4 in disease, they are not able to elucidate the effect of naturally occurring genetic variation, as studied here by the use of our congenic R5. This is mainly supported by the fact that a naturally occurring complete lack of gene expression is extremely rarely found to be a causal factor of a complex diseases and thus studies on knockout mice are usually not relevant in this context.
Compared with reactive oxygen and nitrogen radicals 4-HNE has a relatively long half-life, estimated to be in the order of a couple of minutes in tissues (Esterbauer et al. 1991) . This makes it possible for aldehydic products of lipid peroxidation such as 4-HNE to diffuse some distance from the site of production and react with different proteins, including, for example, albumin, a-synuclein, amyloid b-peptide, but also several GSTs (reviewed in Balogh and Atkins 2011) . Given the wide range of protein targets, the results of HNE exposure and subsequent protein modification will depend on the context and the type of tissue involved. The nervous system is known to be sensitive to oxidative stress and it is therefore of interest to note that expression of Gsta4 is particularly high in the CNS. 4-HNE induces apoptosis of neurons in vitro in a concentration dependent manner and overexpression of Gsta4 in cell lines make cells resistant to 4-HNE-induced apoptosis Awasthi et al. 2003) . A possible way by which 4-HNE increases apoptosis is by a direct effect on p53, of which the concentration, degree of phosphorylation and accumulation in the nucleus increases (Sharma et al. 2008) . From studies of nerve lesion experiments, it is known that axotomized sciatic motoneurons die due to apoptosis and that the neurons are exposed and affected by oxidative damage during the first 7 days after injury, before cell death occurs (Martin et al. 1999) . Here, we find the largest expression differences in Gsta4 early after injury, providing support for the notion that genetic differences affecting Gsta4 levels in the early phase after nerve lesion are important to resist oxidative damage and thereby limit the subsequent degree of neurodegeneration.
Inflammatory activation of microglia is the main endogenous source of ROS in the CNS and activated microglia and signs of lipid peroxidation is frequently observed in a broad range of CNS disorders, such as PD, AD, multiple sclerosis (MS), Huntington's disease, ALS, and stroke (reviewed by Block et al. 2007 ). Even if generation of ROS is generally considered to have detrimental effects, the overall role of microglia activation is more complex, since microglia convey also protective effects and are important for repair. One of the likely reasons for the contrasting results in different models is a variable capability of motoneurons to protect themselves from harmful effects of compounds related to oxidative stress, while gaining from the positive facets of microglia activation. Here, genetically encoded differences in efficiency and levels of enzymes in intrinsic protective systems such as Gsta4 might play an important role.
Gsta4 is, however, not the only candidate for future studies, but also the trans-regulated genes regulated by the VRA1 locus reported in this study can be of relevance in this context. Among the strongest trans-regulated transcripts is D-amino acid oxidase, Dao, which controls the levels of D-serine. D-serine accumulates in the spinal cord in sporadic ALS and a mutation in Dao has recently been linked to familial ALS (Mitchell et al. 2010) . Furthermore, Dao is the 6th most down-regulated gene in brain tissue from AD patients (Twine et al. 2011) . Levels of Dao are lower in animals that are DA homozygotes at D8Rat26. Another VRA1 trans-regulated gene is Duox1, which encodes the enzyme Dual oxidase 1 whose main function is the production of ROS, and thus belong to the same pathway as 4-HNE. Expression of Duox1 was higher in DA homozygotes. Yet, another example is Cyp39a1, a member of the cytochrome P450 family, which has specificity toward metabolizing 24-hydroxycholesterol (Li-Hawkins et al. 2000) . There are many studies on 24-hydroxycholesterol in neurodegenerative diseases, and elevated levels of this cholesterol derivate has been suggested to be one of the most sensitive markers for neuronal damage and loss (Leoni 2009 ). Here, we find the highest expression of Cyp39a1 in DA homozygotes, which may reflect a compensatory mechanism to cope with elevated 24-hydroxycholesterol levels.
In summary, we demonstrate that rat strain differences in the expression of Gsta4 in the nervous system maps to a small genetic fragment regulating survival of axotomized motoneurons, strongly suggesting that natural variation in Gsta4 levels affect the ability of neurons to survive in conditions of distress. Furthermore, several trans-regulated transcripts are involved in the pathways relating to ROS and lipid peroxidation. These results underscore the pivotal role of oxidative stress responses in neurodegeneration and points to the importance of lipid peroxidation as a downstream effector mechanism of motoneuron death.
